Research news

Virtual company to create new Parkinson’s treatments


Parkinson's UK and the University of Sheffield have launched a new £1million virtual biotech company, Keapstone Therapeutics, to combine world-leading research from the University with funding and expertise from the charity to develop new treatments.

Read more about <span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Virtual company to create new Parkinson’s treatments</span>